After a long time, there are some new developments in the company. On September 20, 2024, Emmbi issued 15,50,000 convertible warrants at a price of ₹109 per share, raising ₹10.63 crore. The funds were raised from Kitec Industries (India) Private Limited, a company in the promoter group category.

Avinash Laddha, Managing Director of Kitec Industries, has been a part of Emmbi’s promoter group for a long time. Additionally, Makrand Appalwar (MD of Emmbi), is also Director at Kitec Industries.
Kitec Industries post preferential issue will hold over 8% of Emmbi’s shares.
The last time promoters infused capital was in 2012. Since then, the promoters have gradually increased their stake in the company from 52.2% to 59.83%. After this latest issue, the promoters holding is expected to rise to ~68%.

Kitec Industries is involved in manufacturing, supplying and exporting of easy to install pipes for plumbing and many other applications. The company was promoted as a joint venture with KITECHNOLOGY BV of Netherlands to manufacture revolutionary Multilayer Composite Pipes in India.
Financials of Kitec industries is pretty good compared to the emmbi industries.

I believe there could be a possibility of a merger between Emmbi industries and Kitec Industries in the near future.
Disc. I have made a tracking investment in the company after preferential issue announcement.

As always not sure why the stock will close at UC on news of bonus.

Current i am looking for some company like edelweiss financial services demerger for there alternate asset management business.
apollo pipes management is guiding for good growth and expending ebidta margin started look for it.
maharashtra seamless looking at great valutaion but waiting for next quater to see if they can improve their ebidta margin.

added Thyrocare and exited from All e tech and wockhard.
Thyrocare- margin expection B2C business want to add krsnaa but due to its B2G dependence added thryocare.
All e tech is performing well but due to its current runup value went up and some how i want stay away from SME space for now.going to track it in future.

Wockhard exited due to the probablity of success in molecule is not very high
and i dont want to take that risk when i have better options.

cut some holding from supriya , neuland and added jubilant pharmova, lauras .On pharma i am trying to improve my understanding taking basket approach in it.